| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
DSS, Inc.
13D/A
Amendment 24
DSS · 26253C201
|
86.3% |
9/8/2026
Event 9/3/2026
|
|||
| Heng Fai Ambrose Chan | 86.3% | ||||
| Alset Inc. | 80.0% | ||||
| Global Biomedical Pte. Ltd. | 3.1% | ||||
| Alset International Limited | 71.0% | ||||
|
HWH International Inc.
13D/A
Amendment 14
ESYN · 44852G309
|
27.1% |
8/11/2026
Event 8/7/2026
|
|||
| Heng Fai Ambrose Chan | 27.1% | ||||
| Alset Inc. | 18.7% | ||||
| Alset International Limited | 7.4% | ||||
| Alset Acquisition Sponsor, LLC | 2.0% | ||||
|
HWH International Inc.
13D/A
Amendment 13
ESYN · 44852G309
|
84.7% |
8/7/2026
Event 8/5/2026
|
|||
| Heng Fai Ambrose Chan | 84.7% | ||||
| Alset Inc. | 71.8% | ||||
| Alset International Limited | 28.4% | ||||
| Alset Acquisition Sponsor, LLC | 7.5% | ||||
|
DSS, Inc.
13D/A
Amendment 23
DSS · 26253C201
|
86.8% |
7/9/2026
Event 6/3/2026
|
|||
| Heng Fai Ambrose Chan | 86.8% | ||||
| Alset Inc. | 80.0% | ||||
| Global Biomedical Pte. Ltd. | 3.1% | ||||
| Alset International Limited | 71.0% | ||||
|
HWH International Inc.
13D/A
Amendment 12
ESYN · 44852G309
|
80.6% |
6/9/2026
Event 6/8/2026
|
|||
| Heng Fai Ambrose Chan | 80.6% | ||||
| Alset Inc. | 67.7% | ||||
| Alset International Limited | 24.5% | ||||
| Alset Acquisition Sponsor, LLC | 7.5% | ||||
|
HWH International Inc.
13D/A
Amendment 11
ESYN · 44852G309
|
79.9% |
4/1/2026
Event 3/30/2026
|
|||
| Heng Fai Ambrose Chan | 79.9% | ||||
| Alset Inc. | 66.6% | ||||
| Alset International Limited | 25.3% | ||||
| Alset Acquisition Sponsor, LLC | 7.7% | ||||
|
SHARING SERVICES GLOBAL Corp
13D/A
Amendment 7
SHRG · 819536103
|
99.9% |
3/24/2026
Event 2/4/2026
|
|||
| Heng Fai Ambrose Chan | 99.9% | ||||
| Heng Fai Holdings Limited | 0% | ||||
| Alset Inc. | 99.8% | ||||
| HWH International Inc. | 99.8% | ||||
| Alset International Limited | 12.7% | ||||
| Global Biomedical Pte. Ltd. | 2.8% | ||||
|
SHARING SERVICES GLOBAL Corp
13D/A
Amendment 6
SHRG · 819536103
|
99.8% |
1/20/2026
Event 12/10/2025
|
|||
| Heng Fai Ambrose Chan | 99.8% | ||||
| Heng Fai Holdings Limited | 0% | ||||
| Alset Inc. | 99.8% | ||||
| HWH International Inc. | 99.7% | ||||
| Alset International Limited | 12.7% | ||||
| Global Biomedical Pte. Ltd. | 2.8% | ||||
|
HWH International Inc. (HWH)
13D/A
Amendment 10
ESYN · 44852G309
|
81.3% |
12/1/2025
Event 11/26/2025
|
|||
| Heng Fai Ambrose Chan | 81.3% | ||||
| Alset Inc. | 67.9% | ||||
| Alset International Limited | 26.6% | ||||
| Alset Acquisition Sponsor, LLC | 7.7% | ||||
|
SHARING SERVICES GLOBAL Corp
13D/A
Amendment 5
SHRG · 819536103
|
99.7% |
10/7/2025
Event 10/6/2025
|
|||
| Heng Fai Ambrose Chan | 99.7% | ||||
| Heng Fai Holdings Limited | 0% | ||||
| Alset Inc. | 99.6% | ||||
| HWH International Inc. | 99.5% | ||||
| Alset International Limited | 12.7% | ||||
| Global Biomedical Pte. Ltd. | 2.8% | ||||
|
SHARING SERVICES GLOBAL Corp
13D/A
Amendment 4
SHRG · 819536103
|
99.3% |
9/19/2025
Event 9/17/2025
|
|||
| Heng Fai Ambrose Chan | 99.3% | ||||
| Heng Fai Holdings Limited | 0% | ||||
| Alset Inc. | 99.2% | ||||
| HWH International Inc. | 98.7% | ||||
| Alset International Limited | 12.7% | ||||
| Global Biomedical Pte. Ltd. | 2.8% | ||||
|
Alset Inc.
13D/A
Amendment 23
AEI · 02115D208
|
90.0% |
9/16/2025
Event 9/12/2025
|
|||
| Heng Fai Ambrose Chan | 90.0% | ||||
| HFE Holdings Limited | 9.9% | ||||
|
DSS, Inc.
13D/A
Amendment 22
DSS · 26253C201
|
68.2% |
9/2/2025
Event 8/28/2025
|
|||
| Heng Fai Ambrose Chan | 68.2% | ||||
| Alset Inc. | 47.0% | ||||
| Global Biomedical Pte. Ltd. | 3.4% | ||||
| Alset International Limited | 15.2% | ||||
|
DSS, Inc.
13D/A
Amendment 21
DSS · 26253C201
|
69.6% |
8/22/2025
Event 8/20/2025
|
|||
| Heng Fai Ambrose Chan | 69.6% | ||||
| Alset Inc. | 47.0% | ||||
| Global Biomedical Pte. Ltd. | 3.4% | ||||
| Alset International Limited | 15.2% | ||||
|
Alset Inc.
13D/A
Amendment 22
AEI · 02115D208
|
90.8% |
7/23/2025
Event 7/23/2025
|
|||
| Heng Fai Ambrose Chan | 90.8% | ||||
| HFE Holdings Limited | 9.9% | ||||
|
Alset Inc.
13D/A
Amendment 21
AEI · 02115D208
|
68.3% |
7/2/2025
Event 6/30/2025
|
|||
| Heng Fai Ambrose Chan | 68.3% | ||||
| HFE Holdings Limited | 33.1% | ||||
|
Alset Inc.
13D/A
Amendment 20
AEI · 02115D208
|
65.8% |
4/17/2025
Event 4/15/2025
|
|||
| Heng Fai Ambrose Chan | 65.8% | ||||
| HFE Holdings Limited | 33.0% | ||||
|
Value Exchange International, Inc.
13D/A
Amendment 9
SNPY · 829348200
|
69.9% |
4/17/2025
Event 3/28/2025
|
|||
| Heng Fai Ambrose Chan | 69.9% | ||||
| Alset Inc. | 69.7% | ||||
| Hapi Metaverse Inc. | 68.9% | ||||
|
Impact Biomedical Inc.
13D/A
Amendment 1
04529L106
|
2.9% |
4/4/2025
Event 4/2/2025
|
|||
| Heng Fai Ambrose Chan | 2.9% | ||||
| Alset Inc. | 2.9% | ||||
| Alset International Limited | 2.9% | ||||
| Global Biomedical Pte. Ltd. | 0% | ||||
|
Impact Biomedical Inc.
13D
04529L106
|
16.9% |
4/2/2025
Event 3/31/2025
|
|||
| Heng Fai Ambrose Chan | 16.9% | ||||
| Alset Inc. | 16.9% | ||||
| Alset International Limited | 10.8% | ||||
| Global Biomedical Pte. Ltd. | 3.8% | ||||
|
SHARING SERVICES GLOBAL Corp
13D/A
Amendment 3
SHRG · 819536103
|
96.0% |
4/2/2025
Event 3/31/2025
|
|||
| Heng Fai Ambrose Chan | 96.0% | ||||
| Heng Fai Holdings Limited | 0% | ||||
| Alset Inc. | 95.1% | ||||
| HWH International Inc. | 84.1% | ||||
| Alset International Limited | 12.7% | ||||
| Global Biomedical Pte. Ltd. | 2.8% | ||||
|
SHARING SERVICES GLOBAL Corp (SHRG)
13D/A
Amendment 2
SHRG · 819536103
|
93.7% |
3/20/2025
Event 1/27/2025
|
|||
| Heng Fai Ambrose Chan | 93.7% | ||||
| Heng Fai Holdings Limited | 0% | ||||
| Alset Inc. | 93.6% | ||||
| HWH International Inc. | 62.2% | ||||
| Alset International Limited | 12.7% | ||||
| Global Biomedical Pte. Ltd. | 2.8% | ||||
|
HWH International Inc. (HWH)
13D/A
Amendment 9
ESYN · 44852G309
|
78.4% |
3/13/2025
Event 3/11/2025
|
|||
| Heng Fai Ambrose Chan | 78.4% | ||||
| Alset Inc. | 78.4% | ||||
| Alset International Limited | 30.8% | ||||
| Alset Acquisition Sponsor, LLC | 9.0% | ||||
|
DSS, Inc.
13D/A
Amendment 20
DSS · 26253C201
|
67.6% |
2/10/2025
Event 2/6/2025
|
|||
| Heng Fai Ambrose Chan | 67.6% | ||||
| Alset Inc. | 43.6% | ||||
| Global Biomedical Pte. Ltd. | 3.4% | ||||
| Alset International Limited | 15.2% | ||||
|
Alset Inc.
13D/A
Amendment 19
AEI · 02115D208
|
61.9% |
2/10/2025
Event 2/6/2025
|
|||
| Heng Fai Ambrose Chan | 61.9% | ||||
| HFE Holdings Limited | 3.0% | ||||
|
Alset Inc.
13D/A
Amendment 18
AEI · 02115D208
|
59.2% |
1/29/2025
Event 1/27/2025
|
|||
| Heng Fai Ambrose Chan | 59.2% | ||||
| HFE Holdings Limited | 3.0% | ||||
|
SHARING SERVICES GLOBAL Corp (SHRG)
13D/A
Amendment 1
SHRG · 819536103
|
93.6% |
1/28/2025
Event 1/24/2025
|
|||
| Heng Fai Ambrose Chan | 93.6% | ||||
| Heng Fai Holdings Limited | 0% | ||||
| Alset Inc. | 93.6% | ||||
| HWH International Inc. | 62.2% | ||||
| Alset International Limited | 12.7% | ||||
| Global Biomedical Pte. Ltd. | 2.8% | ||||
|
HWH International Inc. (HWH)
13D/A
Amendment 8
HWH · 44852G101
|
90.2% |
12/27/2024
Event 12/24/2024
|
|||
| Heng Fai Ambrose Chan | 90.2% | ||||
| Alset Inc. | 90.1% | ||||
| Alset International Limited | 35.6% | ||||
| Alset Acquisition Sponsor, LLC | 9.2% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.